Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society
- 1 May 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics B
- Vol. 12 (3) , 155-177
Abstract
A multicenter study on fibrous dysplasia of bone (FD) was promoted by the European Pediatric Orthopaedic Society in 1999 in order to gain insight into the natural history of the disease and to evaluate current diagnostic and therapeutic approaches. We collected and reviewed clinical, radiographic, pathological, and molecular genetic data when possible, from a total of 64 cases diagnosed as either monostotic FD (MFD), polyostotic FD (PFD), or McCune–Albright syndrome (MAS), evaluated or treated in 11 participating centers. Results from the initial analysis of the series indicate five main points: (1) Significant diagnostic pitfalls affect the diagnosis of MFD and, to a lesser extent, PFD in orthopedic centers and allied radiology and pathology facilities, which may be circumvented by the adoption of stringent diagnostic criteria, and in some cases by the analysis of FD-associated GNAS1 mutations. (2) MFD carries a significant risk for fracture in the face of limited disease in the proximal femur, whereas its tendency to progress is restricted to a minority of cases, and long-term outcome is usually satisfactory, regardless of treatment, in non-progressive cases. (3) The profile of tibial disease, both in MFD and in PFD, is markedly different from that of femoral disease. (4) As expected, MAS patients have the most extensive disease and the most complicated course, regularly experience multiple fractures, and require adequate surgical treatment. It appears that conservative treatment of femoral fracture, or curettage and cancellous bone grafting, or fixation with screws and plates are not indicated for the treatment of femoral fractures in these patients and should all be discouraged. Internal fixation with intramedullary nails provides stabilization of extensively affected bones, and prevents further fractures and major deformities, and thus providing a better option both for acute and elective surgery in patients with extensive involvement of the femur or of other limb long bones. (5) Evaluation of patients with FD at orthopedic centers should include, but rarely does, a thorough evaluation of endocrine profile and phosphate metabolism, and proper pathological and radiographic assessment.Keywords
This publication has 30 references indexed in Scilit:
- Clinical Vignette: Angiomatosis of Bone With Localized Mineralization DefectJournal of Bone and Mineral Research, 2001
- Gnathodiaphyseal Dysplasia: A Syndrome of Fibro-Osseous Lesions of Jawbones, Bone Fragility, and Long Bone BowingJournal of Bone and Mineral Research, 2001
- Renal Phosphate Wasting in Fibrous Dysplasia of Bone Is Part of a Generalized Renal Tubular Dysfunction Similar to That Seen in Tumor-Induced OsteomalaciaJournal of Bone and Mineral Research, 2001
- Vascularised bone grafting for fibrous dysplasia of the upper limbThe Journal of Bone and Joint Surgery. British volume, 2000
- Pamidronate treatment of bone fibrous dysplasia in nine children with McCune‐Albright syndromeActa Paediatrica, 2000
- Mutations of the GNAS1 Gene, Stromal Cell Dysfunction, and Osteomalacic Changes in Non–McCune–Albright Fibrous Dysplasia of BoneJournal of Bone and Mineral Research, 2000
- Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells.Journal of Clinical Investigation, 1998
- An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndromeThe Journal of Clinical Endocrinology & Metabolism, 1994
- Long-term effects of intravenous pamidronate in fibrous dysplasia of boneThe Lancet, 1994
- OSTEODYSTROPHIA FIBROSAA.M.A. American Journal of Diseases of Children, 1937